Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 06-2015 | 04-2015 | 03-2015 | 01-2015 | 12-2014 | |
| Sales | 7 | 1,783 | 7 | 0 | -1 |
| Gross Profit | 7 | 1,783 | 7 | N/A | -1 |
| Operating Expenses | 5,674 | -5,595 | 4,908 | 1,006 | 3,840 |
| Operating Income | -5,667 | 7,378 | -4,901 | -1,006 | -3,841 |
| Interest Expense | 169 | 0 | 836 | 0 | 570 |
| Other Income | -3,176 | 4,583 | 553 | -4,178 | -309 |
| Pre-tax Income | -9,012 | 11,961 | -5,184 | -5,184 | -4,720 |
| Net Income Continuous | -9,012 | 11,961 | -5,184 | -5,184 | -4,720 |
| Net Income | $-9,012 | $11,961 | $-5,184 | $-5,184 | $-4,720 |
| EPS Basic Total Ops | -5.60 | 76.68 | -103.36 | N/A | -101.82 |
| EPS Basic Continuous Ops | -5.58 | 84.23 | -103.43 | N/A | -101.81 |
| EPS Diluted Total Ops | -5.60 | 76.68 | -103.36 | N/A | -101.82 |
| EPS Diluted Continuous Ops | -5.58 | 84.23 | -103.43 | N/A | -101.81 |
| EBITDA(a) | $-5,582 | $6,545 | $-4,163 | $-576 | $-3,448 |